These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 768962)

  • 1. The effect of fenfluramine on obesity and plasma lipids of patients with renal allografts.
    Tomlinson SA; Lines JG; Greenfield MA
    Postgrad Med J; 1975; 51 Suppl 1(593):166-70. PubMed ID: 768962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical trial of a new fenfluramine preparation (Ponderax PA).
    Hooper AC
    Postgrad Med J; 1975; 51 Suppl 1():159-60. PubMed ID: 768960
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulatory effects of fenfluramine in obese hypertensive patients.
    Mroczek WJ; Lee WR; Finnerty FA
    Curr Ther Res Clin Exp; 1974 Nov; 16(11):1197-202. PubMed ID: 4214654
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of obesity with fenfluramine (Ponderal)].
    Persson I; Andersen UD; Deckert T
    Ugeskr Laeger; 1973 Sep; 135(36):1932-7. PubMed ID: 4590075
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind clinical trial of fenfluramine in the treatment of obesity.
    Sainani GS; Fulambarkar AM; Khurana BK
    Br J Clin Pract; 1973 Apr; 27(4):136-8. PubMed ID: 4586636
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of the efficacy and acceptability of fenfluramine tablets (BP) and prolonged action capsules.
    Innes JA; Campbell IW; Millar J; Munro JF
    Postgrad Med J; 1975; 51 Suppl 1():160-2. PubMed ID: 768961
    [No Abstract]   [Full Text] [Related]  

  • 7. [Activity of fenfluramine in obese subjects. Relation between dosage, plasma concentration of the drug and its effect on weight loss].
    Magnoni V; Boni S; Bonini LM; Zecca L; Bareggi SR
    Minerva Med; 1982 Jun; 73(24):1703-10. PubMed ID: 7088388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic effects of fenfluramine--a double-blind study.
    Petrie JC; Mowat JA; Bewsher PD; Stowers JM
    Postgrad Med J; 1975; 51 Suppl 1():139-44. PubMed ID: 768954
    [No Abstract]   [Full Text] [Related]  

  • 9. [The therapeutic effect of Fenfluramine on body weight in overweight patients. A controlled clinical study].
    Haug E; Myklebust R
    Tidsskr Nor Laegeforen; 1973 Dec; 93(35):2545-9. PubMed ID: 4589598
    [No Abstract]   [Full Text] [Related]  

  • 10. A collaborative investigation of fenfluramine. Anorexigenic with sedative properties.
    Elliott BW
    Curr Ther Res Clin Exp; 1970 Aug; 12(8):502-15. PubMed ID: 4988837
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trial of fenfluramine in the treatment of obesity in Thai people.
    Chandraprasert S; Israsena T
    Mod Med Asia; 1977 Dec; 13(12):10-2. PubMed ID: 604778
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind clinical trial of fenfluramine.
    Lele RD; Joshi VR; Nathwani AN
    Br J Clin Pract; 1972 Feb; 26(2):79-82. PubMed ID: 4552745
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influence of fenfluramine on the weekly curve of weight loss during obesity].
    Cabezas Cerrato J; Gómez Pérez M; Marco-Mur AL; Camarero E; Fernández-Cruz A
    Rev Clin Esp; 1974 Jan; 132(1):47-52. PubMed ID: 4840227
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination.
    Weintraub M; Hasday JD; Mushlin AI; Lockwood DH
    Arch Intern Med; 1984 Jun; 144(6):1143-8. PubMed ID: 6375610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of obesity with fenfluramine.
    Schindler H; Bielesz G
    Wien Med Wochenschr; 1975 Jan; 125(5):85-8. PubMed ID: 1124579
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic effect of fenfluramine in obese Nigerians--clinical, metabolic and hypotensive properties.
    Adadevoh BK
    Postgrad Med J; 1975; 51 Suppl 1():158. PubMed ID: 768959
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolonged-action fenfluramine in non-diabetic patients with refractory obesity.
    Galloway DB; Logie AW; Petrie JC
    Postgrad Med J; 1975; 51 Suppl 1():155-7. PubMed ID: 768957
    [No Abstract]   [Full Text] [Related]  

  • 18. Fenfluramine, vitamin C and weight loss.
    Wilson CW; Foran K; Innes JA; Watson ML; Ford MJ; Stoddart ME; Munro JF
    Int J Obes; 1978; 2(4):463-5. PubMed ID: 370042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenfluramine and methylcellulose in the treatment of obesity: the relationship between plasma drug concentrations and therapeutic efficacy.
    Hossain M; Campbell DB
    Postgrad Med J; 1975; 51 Suppl 1(593):178-82. PubMed ID: 768965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of a long acting preparation of fenfluramine on body weight, body composition and skinfold thickness in obese subjects.
    Balasse EO; Couturier E; Kornitzer M; Degre S
    Postgrad Med J; 1975; 51 Suppl 1():157. PubMed ID: 768958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.